Robert and Suzanne Tomisch Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio.
Catheter Cardiovasc Interv. 2018 Sep 1;92(3):592-596. doi: 10.1002/ccd.26990. Epub 2017 Mar 15.
The use of transcatheter aortic valve replacement (TAVR) as an acute treatment in severe decompensated bioprosthetic aortic valve disease is not well documented. We describe herein a unique case in which valve-in-valve (ViV) TAVR was successfully used as both an emergency salvage therapy and a bridge to definitive fourth reoperative aortic valve replacement (AVR) in a young patient with cardiogenic shock secondary to bioprosthetic aortic valve stenosis who was dependent on veno-arterial extracorporeal membrane oxygenation (VA-ECMO). © 2017 Wiley Periodicals, Inc.
经导管主动脉瓣置换术（TAVR）作为严重失代偿性生物瓣主动脉瓣疾病的急性治疗方法尚未得到充分记录。我们在此描述了一个独特的病例，在这个病例中，经导管主动脉瓣置换术（ViV）既被成功地用作心源性休克合并生物瓣主动脉瓣狭窄患者的紧急抢救治疗，也被用作依赖体外膜肺氧合（VA-ECMO）的第四次再次主动脉瓣置换术（AVR）的桥梁。
